Aurora Cannabis (ACB) Interest & Investment Income (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Interest & Investment Income of $758373.9 for Q1 2026, down 22.22% year-over-year from $974986.2 in Q1 2025, and up 6.72% quarter-over-quarter from $710632.5 in Q4 2025.
Aurora Cannabis (ACB) Interest & Investment Income (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Interest & Investment Income for 10 consecutive years, with $758373.9 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 22.22% year-over-year to $758373.9; the TTM figure through Mar 2026 stood at $4.2 million (down 43.26% YoY), while the FY2026 annual figure was $4.3 million, down 42.53% from the prior year.
- Interest & Investment Income rose to $758373.9 in Q1 2026 per ACB's latest filing, from $710632.5 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $6.6 million in Q4 2022 and bottomed at $519233.5 in Q2 2022.
- Historically, Interest & Investment Income has averaged $2.0 million across 5 years, with a median of $1.9 million in 2024.
- Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 912.05% — and 2023, when it tumbled 62.9%.
- Aurora Cannabis' Interest & Investment Income stood at $6.6 million in 2022, then sank by 62.9% to $2.4 million in 2023, then retreated by 23.83% to $1.9 million in 2024, then slumped by 61.83% to $710632.5 in 2025, then gained by 6.72% to $758373.9 in 2026.
- Business Quant data shows ACB's Interest & Investment Income at $758373.9 in Q1 2026, $710632.5 in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn | 897,150.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 758,373.92 |
| Dec 31, 2025 | 710,632.51 |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 974,986.15 |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 2.44 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Dec 31, 2022 | 6.59 Mn |
| Sep 30, 2022 | 3.63 Mn |
| Jun 30, 2022 | 519,233.51 |
| Mar 31, 2022 | 738,159.50 |
| Dec 31, 2021 | 1.95 Mn |
| Sep 30, 2021 | 358,278.60 |
| Jun 30, 2021 | -1.05 Mn |
| Mar 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 1.43 Mn |